| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| M-AMSA | definition: See amsacrine (en) number: mass part of speech: noun reliability code: 10 term type: acronym |
| amsacrine | definition: alkylating anticancer drug used in the treatment of acute non-lymphocitic leukemia (ANLL), lymphoma, melanoma and colon and breast cancers. Possible side effects are dose limiting myelosuppression, nausea and vomiting, bone marrow depression, occasional skin rash, mucositis and liver function abnormalities. Intravenous administration. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term |
| AMSA | definition: See def de amsacrine (en) number: mass part of speech: noun reliability code: 10 term type: acronym |
| amsacrina | definition: fármaco alquilante antineoplásico, utilizado para el tratamiento de la leucemia no linfocítica aguda, linfoma, melanoma y cáncer de colon y pecho. Los efectos secundarios más comunes son mielosupresión limitante de dosis, nauseas y vómitos, depresión medular, erupción cutánea, mucositis y disfunción hepática. Administración intravenosa. (es) gender: feminine number: mass part of speech: noun reliability code: 10 term type: main entry term |